|
HNRNPAB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5960999966147E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61879999960313E-07 |
| Normal-vs-Stage2 |
1.564310E-04 |
| Normal-vs-Stage3 |
9.6371000002371E-07 |
| Normal-vs-Stage4 |
5.16399999983541E-07 |
| Stage1-vs-Stage2 |
7.812400E-01 |
| Stage1-vs-Stage3 |
6.547600E-01 |
| Stage1-vs-Stage4 |
3.319400E-01 |
| Stage2-vs-Stage3 |
5.862400E-01 |
| Stage2-vs-Stage4 |
3.092200E-01 |
| Stage3-vs-Stage4 |
5.781400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.21909999767556E-08 |
| Normal-vs-AfricanAmerican |
2.376200E-03 |
| Normal-vs-Asian |
7.73360000039247E-07 |
| Caucasian-vs-AfricanAmerican |
5.377800E-01 |
| Caucasian-vs-Asian |
8.800200E-01 |
| AfricanAmerican-vs-Asian |
4.490000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70269999988371E-07 |
| Normal-vs-Female |
4.89639999656788E-08 |
| Male-vs-Female |
3.739600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.44390000458949E-08 |
| Normal-vs-Age(41-60Yrs) |
1.63736999999609E-05 |
| Normal-vs-Age(61-80Yrs) |
4.47729999997204E-06 |
| Normal-vs-Age(81-100Yrs) |
4.34839999996495E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.463600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.023740E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.693200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.044600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.001000E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.523000E-01 |
| Classical-VS-Follicular |
4.43589999954419E-07 |
| Classical-VS-Other |
2.069200E-01 |
| Classical-VS-Normal |
2.49780196526217E-11 |
| Tall-VS-Follicular |
2.361500E-03 |
| Tall-VS-Other |
2.088200E-01 |
| Tall-VS-Normal |
2.51439999998659E-06 |
| Follicular-VS-Other |
7.093600E-01 |
| Follicular-VS-Normal |
3.127500E-02 |
| Other-VS-Normal |
1.528560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.93240000000628E-05 |
| Normal-vs-N1 |
2.66249999825163E-08 |
| N0-vs-N1 |
7.697200E-03 |
|
|
